RIGI and COVID-19: While other materials (e.g., jetPEI) have beenemployed for local delivery of RIG-I agonists,16,24 it is notable that LNPs have now been locally administered via intramuscularinjection to millions of people receiving COVID-19 mRNA vaccines,which may accelerate the translation of SLR-LNPs for intralesionaltherapy.